Further, survival analysis indicated that a low level of FECH expression was significantly correlated with shorter OS and DFS in ccRCC patients (Fig. 7J, K), which corresponded to the survival analysis of SETD2 (1I, 1J). This evidence concerns the gene SETD2 and nonpapillary renal cell carcinoma.